Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pdk 1'

Search results for: 'research area pi3k akt signaling pdk 1'

Items 1-10 of 11

Page
per page
  1. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  2. XMU-MP-1
    A8735 XMU-MP-1
     2 Citation
    Target: MST
    Summary: MST1/2 inhibitor, potent and selective
      ≥41.6 mg/mL
  3. KU-60019
    A8336 KU-60019
     2 Citation
    Target: ATM/ATR
    Summary: ATM kinase inhibitor,potent and selective
      ≥27.4 mg/mL
  4. GSK461364
    A8441 GSK461364
     3 Citation
    Target: PLK
    Summary: Plk1 inhibitor
  5. BIBR 953 (Dabigatran, Pradaxa)
    A4077 BIBR 953 (Dabigatran, Pradaxa)
    Summary: Thrombin inhibitor,potent,reversible and direct
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  6. GSK1059615
    B2176 GSK1059615
    Target: PI3K|mTOR
    Summary: PI3K and mTOR inhibitor,potent and reversible
      insoluble in EtOH; insoluble in H2O; ≥8.33 mg/mL
  7. Semagacestat (LY450139)
    A8190 Semagacestat (LY450139)
    Summary: γ-secretase inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  8. (-)-Huperzine A
    A1932 (-)-Huperzine A
    Target: NMDA Receptors|AChE
    Summary: NMDA receptor antagonist/AChE inhibitor
      insoluble in H2O; ≥12.12 mg/mL
  9. SC-514
    B1585 SC-514
    Summary: ATP-competitive IKK-2 inhibitor, orally active
      insoluble in EtOH; insoluble in H2O; ≥50.4 mg/mL
  10. CVT-313
    A3336 CVT-313
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Cdk2 inhibitor
      ≥20 mg/mL

Items 1-10 of 11

Page
per page